NCT06497569 Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
| NCT ID | NCT06497569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Condition | GastroEsophageal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-07-26 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-07-26 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.
Eligibility Criteria
Inclusion Criteria: * Participants must be 18 years of age or older * Participants must have locally advanced or metastatic gastroesophageal cancer (GEC) * Participants must plan to initiate chemotherapy and/or radiation therapy with a plan to have surgery or definitive treatment follow up at Moffitt * Participants must be able to speak and read Spanish and/or English * Participants must be able to provide informed consent Exclusion Criteria: * Participants have a documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g. severe dementia) * Use of feeding tubes at the time of study enrollment
Contact & Investigator
Amir Alishahi Tabriz, MD, PhD, MPH
PRINCIPAL INVESTIGATOR
Moffitt Cancer Center
Frequently Asked Questions
Who can join the NCT06497569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying GastroEsophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06497569 currently recruiting?
Yes, NCT06497569 is actively recruiting participants. Contact the research team at Emma.Hume@moffitt.org for enrollment information.
Where is the NCT06497569 trial being conducted?
This trial is being conducted at Tampa, United States, Chapel Hill, United States.
Who is sponsoring the NCT06497569 clinical trial?
NCT06497569 is sponsored by H. Lee Moffitt Cancer Center and Research Institute. The principal investigator is Amir Alishahi Tabriz, MD, PhD, MPH at Moffitt Cancer Center. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.